- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04956315
Accuracy and Stability of a New Automatic Knee Arthrometer in Diagnosing ACL Rupture
July 7, 2021 updated by: Peking University Third Hospital
Accuracy and Stability of a New Automatic Knee Arthrometer in Diagnosing Anterior Cruciate Ligament Rupture
We introduced an automatic knee arthrometer (AKA) and aimed to evaluate the repeatability and effectiveness thereof in diagnosing ACL rupture compared with the KT-2000.
Study Overview
Status
Completed
Conditions
Detailed Description
The AKA was compared to the KT-2000 at 134 N in this study, the anterior displacement and difference of both knees of every subject were measured.
The first protocol was designed to evaluate examiner effect (level of experience) and contralateral-side effect (left or right knee) in a single healthy subject, ten times, on ten consecutive days.
The second was to compare the stability in 20 healthy subjects, with a single experienced examiner.
Third, we recruited 200 ACL rupture and 200 healthy subjects as contrast to compare the accuracy of the devices in diagnosing ACL rupture.
Study Type
Observational
Enrollment (Actual)
421
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100191
- Peking University Third Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
one healthy subject was tested with both devices for ten consecutive days to estimate examiner effect; 20 healthy subjects were tested with both devices to determine the method effect; 200 medicine students volunteered as healthy subjects; each with pain-free knees in the last three months, and without a history of knee injury; 200 patients with ACL rupture from our institution were also included.
Description
Inclusion Criteria:
- patients with ACL rupture from our institution were included. All patients were diagnosed by sports medicine specialists based on clinical manifestation, combined with imaging examinations, and hospitalized for further surgery.
Exclusion Criteria:
- Patients aged <18 or >45 years, with combined multiple knee ligament injury combinations, and/or limited range of motion of the knee (unable to flex to 20-30°)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Examiner effect group
Two examiners performed the test on one healthy subject with both devices for ten consecutive days.
We measured the AD of both knees and calculated the ADD of every test.
We evaluated the contralateral-side effect by comparing the AD standard deviations of each knee with both devices, and compared the average ADD tested by different examiners with the same device, to estimate examiner effect.
|
The experienced examiner performed tests on 20 healthy subjects
|
|
Method effect group
The experienced examiner performed tests on 20 healthy subjects using both devices.
The means and standard deviations of both knees were calculated.
We examined the difference in measurements using each device to determine the method effect.
|
Two examiners performed the test on one healthy subject with both devices for ten consecutive days.
|
|
Equipment effectiveness group
The experienced examiner performed tests on 200 ACL ruptureand 200 healthy subjects using each device.
Effectiveness was analyzed using 1.5 mm and 3 mm threshold values in ACL tears.
|
200 ACL rupture and 200 healthy subjects were recruited as contrast to compare the accuracy of the devices in diagnosing ACL rupture.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Side-to-side difference (SSD)
Time Frame: within 3 months after ACL rupture
|
Side-to-side difference (SSD)at 134 N
|
within 3 months after ACL rupture
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: yingfang ao, M.D., Peking University Third Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 30, 2020
Primary Completion (Actual)
July 1, 2020
Study Completion (Actual)
December 31, 2020
Study Registration Dates
First Submitted
June 27, 2021
First Submitted That Met QC Criteria
July 7, 2021
First Posted (Actual)
July 9, 2021
Study Record Updates
Last Update Posted (Actual)
July 9, 2021
Last Update Submitted That Met QC Criteria
July 7, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- M2020263
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.